The Federal Circuit Helps a Patent Troll Block Public Access to Court Records

For more than three years, EFF has been fighting for public access to court records in a patent case between Uniloc, one of the world’s most prolific patent trolls, and Apple, one of the world’s biggest tech companies. The district court has ruled...

Does Prior Publication Extinguish a Trade Secret?

by Dennis Crouch Masimo Corp. v. True Wearables, Inc. (Fed. Cir. 2022) (nonprecedential) This trade-secrecy decision includes a few interesting …

Case: Patents/Obviousness (P.T.A.B.)

Challenged claims of Engle Grange LLC’s patent directed to a keyless ignition start system in which authentication of a coded key fob is carried out twice are unpatentable, the PTAB held, in an inter partes review by Unified Patents LLC. Unified...

Federal Circuit Reverses Judge Stark Decision, Finds Computer Network Patent Eligible | JD Supra

The US Court of Appeals for the Federal Circuit concluded that a representative claim was directed to a patent-eligible improvement to computer...

Federal Circuit Dataset & Stats: 2021 Update

By Jason Rantanen Happy 2022! As I’ve done for the last few years, below I provide some statistics on what …

Dennis Crouch, Joined by Gene Quinn (Watchtroll), Still Attacking PTAB to Protect Patent Trolls and Software Patents

The attacks on the Patent Trial and Appeal Board (PTAB) and those who enable PTAB have not ended; instead, these attacks have intensified again because the Supreme Court will weigh in soon

Patent case: Biogen International GmbH v. Mylan Pharmaceuticals Inc., USA - Kluwer Patent Blog

A person of ordinary skill in the art could not determine the effective dose of the active ingredient in Tecfidera from the original patent specification. A West Virginia federal district court’s decision that certain claims of a Biogen patent...

Rounding Errors in Patent Law

by Dennis Crouch Astrazeneca AB v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2021) This case helps show that patent law has …

Biogen Int'l GmbH v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2021)

By Kevin E. Noonan -- As is well-known, Congress established the Federal Circuit as a circuit court of appeals to harmonize U.S. patent law in an environment where regional Circuit Courts had developed their own judicial interpretations of the...

Arsus final decision affirmed by Federal Circuit — Unified Patents

On November 16, 2021, the United States Court of Appeals for the Federal Circuit summarily affirmed the PTAB’s ruling that Arsus's disclaimer of all challenged claims of U.S. Patent 10,259,494 should be treated as a request for adverse judgment...

SynKloud Technologies abandons own Federal Circuit appeal — Unified Patents

On November 12, 2021, SynKloud Technologies filed a motion to dismiss its Federal Circuit appeal. Unified had won on all issues at the PTAB in IPR2019-01655 , resulting in all claims of SynKloud’s U.S. Patent 9,098,526 being found unpatentable....

FCBA Remote Program on PTAB

The Federal Circuit Bar Association (FCBA) PTAB/TTAB Committee will be offering a remote program entitled "PTAB Review: Effects of Arthrex and Potential Future Reforms" on December 3, 2021 from 12:00 pm to 1:00 pm (ET). Robert Bauer of Bauer Law...

CardioNet, LLC v. InfoBionic, Inc. (Fed. Cir. 2021)

By Kevin E. Noonan -- The Federal Circuit continued its stringent (if misguided) application of the scope of subject matter eligibility by invalidating claims asserted in CardioNet, LLC v. InfoBionic, Inc. The case arose over InfoBionic's alleged...